D. A. S. Compston

18.9k citations

180 papers · 13.5k indexed · 3 hit papers · h-index 63

Impact in

Pathology and Forensic Medicine top 0.02%
- Multiple Sclerosis Research Studies
Neurology top 0.1%
- Peripheral Neuropathies and Disorders
- Neuroinflammation and Neurodegeneration Mechanisms

Papers in

Pathology and Forensic Medicine 96
- Multiple Sclerosis Research Studies 93
- Systemic Sclerosis and Related Diseases 15
Developmental Neuroscience 22
- Neurogenesis and neuroplasticity mechanisms 22

Co-authors: Neil Scolding Peter S. Harper Alasdair Coles Susan Huson Robert Swingler Neil P. Robertson W. I. McDonald B. Paul Morgan
Journals: Neurology (31 papers)Journal of Neurology Neurosurgery & Psychiatry (30 papers)Brain (15 papers)Journal of Neuroimmunology (15 papers)Journal of Neurology (12 papers)
Partner nations: United Kingdom United States Canada

In The Last Decade

D. A. S. Compston

180 papers receiving 13.1k citations

Hit Papers

align trajectories log scale

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial 2012 · 884 citations

Peers

Countries citing papers authored by D. A. S. Compston

Since Specialization

Citations

This map shows the geographic impact of D. A. S. Compston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. A. S. Compston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. A. S. Compston more than expected).

Fields of papers citing papers by D. A. S. Compston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. A. S. Compston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. A. S. Compston. The network helps show where D. A. S. Compston may publish in the future.

Co-authors

The 25 scholars most cited alongside D. A. S. Compston, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. A. S. Compston Line = papers co-authored together D. A. S. Compston links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223 Journal of Neurology ·Brian Steingo, Yaser Al Malik, Ann Bass, Regina Berkovich, J. Witt, Óscar Fernández, Carolina Ionete, Luca Massacesi, Sven G. Meuth, Dimos D. Mitsikostas, Gabriel Pardo, Renata Simm, Anthony Traboulsee, Zia Choudhry, Nadia Daizadeh, D. A. S. Compston, (unknown)	2020	41
2	Durable Effect of Alemtuzumab on Clinical Outcomes Over 5 years in Treatment-Naive Patients With Active Relapsing-Remitting Multiple Sclerosis Despite Most Patients Not Receiving Treatment for 4 Years: CARE-MS I Extension Study Multiple Sclerosis Journal ·Pamela McCombe, HP Hartung, Eva Havrdová, Krzysztof Selmaj, David Margolin, Linda Kasten, D. A. S. Compston	2016	2
3	Alemtuzumab-Treated Patients with RRMS Demonstrate Durable Slowing of Brain Volume Loss Over 5 Years Despite Most Being Treatment-Free for 4 Years: CARE-MS I and II Extension Study (S51.001) Neurology ·Sven Schippling, Jeffrey A. Cohen, Alasdair Coles, D. A. S. Compston, Edward Fox, Massimo Filippi, Hans‐Peter Hartung, Eva Havrdová, Krzysztof Selmaj, Frederik Barkhof, David Margolin, Karthinathan Thangavelu, Douglas L. Arnold	2016	2
4	Pregnancy outcomes in patients with active RRMS who received alemtuzumab in the clinical development program Multiple Sclerosis Journal ·Anat Achiron, Christina Chambers, Turkia Al-moustafa, P Combe, Wesley Dobrychtop, David Margolin, Linda Kasten, D. A. S. Compston	2015	9
5	Slowing of Brain Volume Loss in Patients With Relapsing-Remitting Multiple Sclerosis After Switching From Subcutaneous Interferon Beta-1a to Alemtuzumab (P7.264) Neurology ·Jeffrey Cohen, Douglas L. Arnold, Alasdair Coles, Edward Fox, Hans‐Peter Hartung, Eva Havrdová, Krzysztof Selmaj, David Margolin, Linda Kasten, Michael Panzara, D. A. S. Compston	2015	2
6	Improvement in Clinical Outcomes Following Switch From Subcutaneous Interferon Beta-1a to Alemtuzumab: CARE-MS II Extension Study (P7.278) Neurology ·Edward Fox, Gavin Giovannoni, Douglas L. Arnold, Alasdair Coles, Hans‐Peter Hartung, Eva Havrdová, Krzysztof Selmaj, David Margolin, Jeffrey Palmer, Michael Panzara, D. A. S. Compston	2015	2
7	Immune competence after alemtuzumab treatment of multiple sclerosis Neurology ·jipranata jipranata, Orla Tuohy, D. A. S. Compston, Dinakantha Kumararatne, Alasdair Coles, Joanne Jones	2013	102
8	HLA-DRB1 and multiple sclerosis in Malta Neurology ·G Dean, Tai Wai Yeo, An Goris, Clare Taylor, Reyna S. Goodman, Marta Elian, A. Mammadova, Mohammed Hussein Haider, Alex E. Felice, 健治佐竹, سیاوش سلطانیان, D. A. S. Compston	2007	30
9	Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis European Journal of Immunology ·Amanda Cox, Sara Thompson, Joanne Jones, 阿拉塔, G Hale, Herman Waldmann, D. A. S. Compston, Alasdair Coles	2005	238
10	Continuing optic nerve atrophy following optic neuritis: a serial MRI study Multiple Sclerosis Journal ·Simon J. Hickman, Roberto Vetro gnani, P A Brex, David MacManus, Neil Scolding, D. A. S. Compston, David H. Miller	2002	74
11	Microglia-derived IGF-2 prevents TNFα induced death of mature oligodendrocytes in vitro Journal of Neuroimmunology ·Richard Nicholas, Sarah Stevens, Mark Wing, D. A. S. Compston	2002	71
12	Interferon-beta inhibits mitogen induced astrocyte proliferation in vitro Journal of Neuroimmunology ·Omar Malik, D. A. S. Compston, Neil Scolding	1998	24
13	The effect of intravenous aminophylline on essential tremor British Journal of Clinical Pharmacology ·Maryna Solodkaya, R. W. Marshall, Tri Herliana, Behruz M. Panahi, D. A. S. Compston, PA Routledge	1997	3
14	Age–adjusted recurrence risks for relatives of patients with multiple sclerosis Brain ·Neil P. Robertson, M Fraser, J. Deans, David Clayton, Niki L. Walker, D. A. S. Compston	1996	158
15	Multiple sclerosis and the HLA-D region: linkage and association studies Journal of Neuroimmunology ·H. Kellar-Wood, Nicholas Wood, Peter Holmans, David Clayton, Neil P. Robertson, D. A. S. Compston	1995	55
16	Sequence of the human homologue of a mitochondrially encoded murine transplantation antigen in patients with multiple sclerosis Journal of Neurology ·R. M. Chalmers, A E Harding, Nancy P. Robertson, H. Kellar-Wood, D. A. S. Compston	1995	20
17	Grovith factors fail to protect rat oligodendrocytes against humoral injury in vitro Neuroscience Letters ·Neil Scolding, D. A. S. Compston	1995	10
18	No linkage between multiple sclerosis and the T cell receptor α chain locus Journal of the Neurological Sciences ·Marica Eoli, Nicholas Wood, H. Kellar-Wood, Peter Holmans, David Clayton, D. A. S. Compston	1994	7
19	The pathogenesis of demyelinating disease Progress in Neurobiology ·Neil Scolding, John Zajicek, Nicholas Wood, D. A. S. Compston	1994	43
20	IMMUNOCYTOCHEMICAL LOCALIZATION OF THE TERMINAL COMPLEMENT COMPLEX IN MULTIPLE SCLEROSIS Neuropathology and Applied Neurobiology ·D. A. S. Compston, B. Paul Morgan, Anthony K. Campbell, P. Wilkins, G. Cole, Norman D. Thomas, Bharat Jasani	1989	155

About D. A. S. Compston

D. A. S. Compston is a scholar working on Pathology and Forensic Medicine, Developmental Neuroscience, Neurology, Immunology and Rheumatology, having authored 180 papers that have together received 13.5k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (93 papers), Neurogenesis and neuroplasticity mechanisms (22 papers), Neuroinflammation and Neurodegeneration Mechanisms (21 papers), Immunotherapy and Immune Responses (20 papers), Systemic Sclerosis and Related Diseases (15 papers), Systemic Lupus Erythematosus Research (14 papers), T-cell and B-cell Immunology (13 papers) and Rheumatoid Arthritis Research and Therapies (12 papers). The work is most often cited by research in Pathology and Forensic Medicine (7.7k citations), Neurology (4.3k citations), Developmental Neuroscience (970 citations), Immunology (3.5k citations) and Rheumatology (2.5k citations). D. A. S. Compston has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Neil Scolding, Peter S. Harper, Alasdair Coles, Susan Huson, Robert Swingler, Neil P. Robertson, W. I. McDonald, B. Paul Morgan, J. Deans and David H. Miller. Their work appears in journals such as Neurology, Journal of Neurology Neurosurgery & Psychiatry, Brain, Journal of Neuroimmunology and Journal of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact